Clinical Trials

Waiting: the FDA & aducanumab

June 4, 2021 — 0 Comments

Clinical Trials

Donanemab P2 “encouraging”: Really? It Misses Investigators’ Own Target; Cognitive Enhancers Up Next…

May 6, 2021 — 0 Comments

Clinical Trials, Research Strategy

Exercise & The Little Gray Cells in AD? Eye Opening Paper May Refute That…

April 6, 2021 — 0 Comments

Clinical Trials

“Alzheimer’s Germ Quest”: no $1M winner, but 8 candidate germs!? Other Alzheimer $MM Challenges…

March 1, 2021 — 1 Comment

Clinical Trials, Research Strategy

Off BACE: 70 Year Olds Bounce Back From BACE Drug Cognitive Decline?!

February 7, 2021 — 0 Comments

Clinical cases, Clinical Trials

Lilly’s amyloid donanemab in Phase 2; how a neurologist approaches dementia in a man with memory, behavior problems: NEJM CPC 12.31.20

January 13, 2021 — 0 Comments

Clinical Trials, Research Strategy

Inflammaging & Fountain of Youth?

November 9, 2020 — 1 Comment

Clinical Trials, Research Administration, Research Strategy

Dementia 2020: AAIC, ACT meetings, Lancet updated; no new real therapy, CELL and CTAD strategy papers

August 31, 2020 — 0 Comments

Clinical Trials, Research Strategy

Down Syndrome and Alzheimer’s; Drugs in the Pipeline 2020

July 27, 2020 — 0 Comments

Clinical Trials

Nasal insulin, baby aspirin disappoint; Can alcohol help? BP control, sleep

July 7, 2020 — 0 Comments